IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $613,000 | -28.3% | 464,490 | 0.0% | 0.00% | -33.3% |
| Q1 2018 | $855,000 | -12.8% | 464,490 | 0.0% | 0.01% | -14.3% |
| Q4 2017 | $980,000 | -5.4% | 464,490 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $1,036,000 | +29.7% | 464,490 | 0.0% | 0.01% | +40.0% |
| Q2 2017 | $799,000 | -30.3% | 464,490 | 0.0% | 0.01% | -37.5% |
| Q1 2017 | $1,147,000 | – | 464,490 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 2,030,604 | $4,285,000 | 0.70% |
| Virtus ETF Advisers LLC | 180,348 | $381,000 | 0.48% |
| Bain Capital Public Equity Management, LLC | 4,564,744 | $9,632,000 | 0.35% |
| Baker Brothers Advisors | 18,315,802 | $38,646,000 | 0.34% |
| Stanley-Laman Group, Ltd. | 483,773 | $1,021,000 | 0.22% |
| FIRST MIDWEST BANK TRUST DIVISION | 493,689 | $1,042,000 | 0.13% |
| GMT CAPITAL CORP | 3,875,546 | $8,178,000 | 0.08% |
| Vident Investment Advisory, LLC | 640,270 | $1,351,000 | 0.06% |
| SABBY MANAGEMENT, LLC | 307,987 | $650,000 | 0.06% |
| Palo Alto Investors LP | 616,355 | $1,301,000 | 0.06% |